Our R&D Program Leaders partner with clients to develop key decision criteria and help facilitate decision-making throughout your drug development program. They act as the single point of accountability, providing:

  • Strategic guidance
  • Stewardship
  • Operational support

Strategic guidance to steer your program

We are accountable for the strategy and execution of complex, multi-disciplinary development programs with over-arching strategic support.

  • Identify critical target product profile criteria to differentiate and increase potential commercial value
  • Align business goals with program objectives
  • Evaluate, design and identify alternative R&D strategies
お問合わせ
Strategic guidance to steer your program
Stewardship to deliver a seamless experience and support

Stewardship to deliver a seamless experience and support

We have extensive experience leading integrated, multi-disciplinary drug development teams with expert communication and management.

  • Effectively manage and navigate across and between organizations
  • Provide portfolio governance leadership and management
  • Lead stakeholder management
まずはご相談ください

Operational support to plan, anticipate and mitigate risk

  • Ensure quality project delivery on time & to budget
  • Identify risks and develop mitigation plans
  • Forecast and plan scenarios
詳細を表示
Operational support to plan, anticipate and mitigate risk
Yvonne
Yvonne Wilding Senior Director, R&D Program Leadership

Yvonne has over 20+ years leading strategic design and operational delivery of new medicines and novel drug delivery device projects. She has worked on more than 100 successful global pharma regulatory submissions in respiratory, cardiovascular, oncology immunology, and orphan drug indications in both small molecules, orphan drugs and biologicals.

トップに戻る
Powered by Translations.com GlobalLink OneLink Software